Nuveen Asset Management, LLC Cytek Biosciences, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 317,301 shares of CTKB stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
317,301
Previous 317,301
-0.0%
Holding current value
$1.82 Million
Previous $1.77 Million
0.73%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
71.7MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$67.6 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$54.5 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$38.2 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$23.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $773M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...